Simian virus 5 (SV5) isolates derived after co-cultivation of human bone marrow aspirates of multiple sclerosis (MS) patients were shown by immunoprecipitation, cross-neutralization and haemagglutination inhibition techniques to be similar antigenically but not identical to the prototype strain. Analyses of human sera (MS and control) showed that about 20 ~ contained neutralizing antibodies to SV5 and immunoprecipitated the specific SV5 HN polypeptide. A competition assay using a specific SV5 monoclonal antibody confirmed that a human serum containing such neutralizing activity also blocked a specific SV5 epitope whereas another human serum with demonstrable antibodies to the related human parainfluenza virus type 2 did not block this epitope. These tests therefore suggested that SV5 can infect humans. However, there was no indication, on the basis of these tests, of any aetiological relationship of the SV5 infection to the induction of MS.
INTRODUCTION
Simian virus 5 (SV5) was originally isolated from rhesus and cynomolgus monkey kidney cell cultures and was therefore presumed to be of simian origin (Hull et al., 1956) . However, there have also been a number of reports of the isolation of SV5-1ike viruses from canine sources and accounts of isolation from human tissues (for review, see Hsiung, 1972) . There has also been a more recent report of the isolation of an SV5-related paramyxovirus from a patient with subacute sclerosing panencephalitis after co-cultivation in vitro of peripheral blood leukocytes with indicator tissue culture cells (Robbins et al., 1981) . Notwithstanding these observations, it has never been generally accepted that the virus can infect humans particularly since there have been studies showing that the virus can be detected as a contaminant in some tissue culture cell lines (Zakstelskaya et al., 1976) .
Our interest in this virus has arisen from a study of the properties of a series of virus isolates obtained after the co-cultivation and passage of bone marrow aspirates from multiple sclerosis (MS) patients with tissue culture cells (Mitchell et aL, 1978) . Although the initial observations were complicated by the presence of mycoplasmas (Mitchell et al., 1979) , neutralization tests and fluorescent antibody techniques have clearly shown that the isolates were related to SV5. One of these isolates (designated RQ) was examined together with the prototype SV5 strain using immunoprecipitation techniques and both were shown to be closely related, but not identical. In addition, it was shown that they are related to human parainfluenza virus type 2 (PF-2), but not to type 1 (PF-1) or type 3 (PF-3), the major difference being in the glycoprotein haemagglutinin-neuraminidase (HN) component (Goswami & Russell, 1982) . It was also noted during these studies that the HN and NP (nucleoprotein) polypeptides of the RQ isolate had slightly different mobilities from the corresponding prototype SV5 polypeptides. To investigate these antigenic relationships in greater depth and to provide more highly specific reagents, t Visiting worker from The Brompton Hospital. :~ Present address: Department of Biochemistry and Microbiology, University of St. Andrews, Fife, U.K.
0022-1317/84/0000-6158 $02.00 © 1984 SGM monoclonal antibodies against both SV5 and PF-3 virus have been prepared (Goswami & Russell, 1983) . Two different epitopes have been detected on the SV5 HN polypeptide, one being specific to the SV5 and the other also cross-reacting with the PF-2 HN polypeptide. Similar epitopes were also observed on the PF-3 HN polypeptide, namely one showing cross-reactivity with the HN of PF-1 and the other being specific to PF-3, there being no cross-reactions with SV5 and PF-2 virus. The present study assesses the significance of the SV5 isolations from bone marrow aspirates after co-cultivation in vitro. Could they arise merely as a result of adventitious laboratory contamination of cell cultures or do they reflect the possibility that SV5 can infect humans and can persist in tissues, as do some other paramyxoviruses?
We have compared these isolates with prototype SV5 and PF-2 virus and analysed human sera from MS and control patients by neutralization of infectivity, haemagglutination inhibition and immunoprecipitation techniques, utilizing specific monoclonal antibodies where appropriate. The results strongly suggest that SV5 can infect humans but there is no indication, on the basis of these tests, of any specific relationship between SV5 infection and multiple sclerosis.
METHODS
Isolation oft, irusfrom bone marrow. Bone marrow aspirates from 18 MS patients and 15 control patients were used in the co-cultivation studies over a period of 4 years (1976 to 1980) . Bone marrows from eight MS patients and six control patients were treated with lysolecithin and fused with MRC-5 cells. The technique of co-cultivation and passaging was carried out on different dates and the details of technique have been described by Mitchell et al. (1978) .
Cells, virus assay and neutralization. Vero cells were propagated as monolayers in Eagle's MEM with 10~ newborn calf serum. Cells were suspended using trypsin/versene standard solutions, washed in medium containing calf serum and, when used for assay, resuspended in medium containing 2.5 ~ serum. Virus infectivity was assessed by making appropriate twofold dilutions of 50~tl of virus in 96-well microtitre plates (Nunc), adding 100 ~tl of a suspension of Vero cells at 4 x 105 cells/ml and incubating for 4 or 5 days at 37 °C in a humidified atmosphere of 5 ~ CO2, followed by fixation with formal saline and staining with crystal violet. Neutralization was also carried out in microtitre plates by making 50 ~tl vol. of a standard dilution of virus containing approx. 50 p.f.u, and incubating overnight at 4 °C with 50 Ixl of serial dilutions of sera. Then, 100 ~tl Vero cell suspension (4 x 105 ceUs/ml) was added and the cells fixed and stained after 4 or 5 days incubation at 37 °C. The dilution of serum giving a 50% reduction in the degree of c.p.e, was taken as the endpoint. Primary chick embryo fibroblasts were used to quantify Sendal virus.
Haemagglutination inhibition (HI) . Microtitre plates were used with 100 ~tl reaction mixtures containing dilutions of sera or monoclonal antibodies with a standard concentration of virus antigen. After incubation for 1 h at room temperature, 100 ~1 of 1~ chick erythrocyte suspension was added to each well and the 50~ haemagglutination endpoint determined.
Antisera. Standard diagnostic rabbit antisera against prototype SV5, PF-1, PF-2, PF-4a, PF-4b and mumps viruses were obtained from the Department of Microbial Reagents and Quality Control, Central Public Health Laboratories, Colindale, London, U.K. Antiserum against the LN isolate was prepared by standard intramuscular injection of clarified infected tissue culture supernatant with adjuvant in a rabbit followed by boosting with the same antigen.
Antisera against purified SV5 (RQ) and PF-3 virus were prepared by standard alum precipitation procedures (Goswami & Russell, 1982; Mautner & Willcox, 1974) . A few days before bleeding, the rabbits were given an intravenous boost with purified virus (without alum). Sendal virus antiserum was obtained from rabbits by intramuscular inoculation of purified virus and was kindly supplied by Mr A. Douglas of the Division of Virology, NIMR.
Monoclonal antibodies against SV5 and PF-3 were prepared and characterized as described previously (Goswami & Russell, 1983) .
Human sera. These were obtained from MS patients in the London area who were considered to have probable or definite MS based on accepted criteria. The control sera were derived from patients in London with conditions other than MS (including other distinct neurological entities) and were age-and sex-matched with the MS patients.
Labelling of infected cell polypeptides and immunoprecipitation. Monolayers of Vero cells in 50 mm plastic dishes were infected with virus and labelled with [35S]methionine for 1 h at 72 h after infection. The infected cells were then extracted and the labelled extracts immunoprecipitated and analysed by SDS-PAGE and autoradiography as described previously (Goswami & Russell, 1983) . Labelled adenovirus-infected cell extracts were used as molecular weight markers. Mycoplasma screening. Infected and uninfected cells were tested using the fluorescent DAP1 procedure (Russell et al., 1975) .
Competition assay. ~ ZSl-labelled immunoglobulin was prepared from A12(SV5 HN-I) ascitic fluid by binding to a column of Protein A-agarose (Bethesda Research Laboratories) and eluting with 50 mM-glycine-HCl buffer pH 2.8 (Goswami & Russell, 1983 ). Fractions were collected in 100 m~-Tris-HCl pH 8.6 and analysed for u.v. absorption at 280 nm. The peak fractions were dialysed against phosphate-buffered saline (pH 7.2), and the IgG was iodinated by standard techniques using chloramine T (Amersham). Nitrocellulose paper BA85 (Schleicher & Schiill) was cut to an appropriate size, marked with a ball-point pen into 1 cm squares, and transferred into a flat plastic box (17 × 12 cm). Purified SV5 (RQ) (1 ml of approx. 1 × 107 p.f.u./ml) was diluted 1:10 in TBS (0.9~ NaC1, 10 mM-Tris-HCl pH 7.6) and added to the box and the paper soaked for 1 h on a rocker at 37 °C. The excess antigen was removed and the paper washed for 20 min at 37 °C in TBS containing 3~ bovine serum albumin (BSA) and then blotted dry. Mixtures were prepared in 96-well microtitre plates of twofold serial dilutions of 20 lal of sera in TBS and 20 ~tl of a predetermined optimum dilution of the ~25I-labelled IgG (approx. 105 c.p.m.). Two ~tl aliquots were then added to the antigen-treated paper and incubated for 30 min in a humidified atmosphere at 37 °C. The paper was then gently washed twice with TBS containing 3~ BSA and 0-2~ NP40 for periods of 15 rain, twice with TBS alone, dried and mounted for autoradiography.
The spots thus obtained on the autoradiogram were quantified by cutting out the film and digesting with 1 ml 1 M-NaOH at room temperature for 2 h. After vortex mixing the eluted silver grains were maintained in suspension by adding glycerol to a final concentration of 30~ and the absorbance at 500 nm determined using a Beckman DU7 spectrophotometer (Suissa, 1983) .
RESULTS

Isolation of S V5 after co-cultivation of bone marrow aspirates with indicator tissue culture cells
Five different isolates were obtained in four different series of experiments over a period of 4 years after co-cultivation of bone marrow aspirates with MRC-5 cells and fusion with lysolecithin (Mitchell et al., 1978 (Mitchell et al., , 1979 . Varying c.p.e.s were manifest in most of the initial 33 bone marrow cultures (derived from both MS patients and non-MS patients) but only five of these (all derived from MS patients) were capable of transmitting a c.p.e, on multiple passage in MRC-5 and then in Vero cells. The history and designation of these isolates are documented in Table 1 . Two bone marrow aspirates from non-MS patients did show some cytopathic changes in primary cultures and three others from MS patients produced c.p.e, after one passage but all failed to transmit the effect. The initial identification of the isolates was by neutralization and fluorescent antibody methods using standard SV5 rabbit antisera obtained from the Central Public Health Laboratories. Confirmation of these results by immunoprecipitation and other methods has been documented previously (Goswami & Russell, 1982 , 1983 . The indicator Vero and MRC-5 ceils were regularly screened for the presence of paramyxovirus antigens by fluorescent antibody methods and were always negative. Most of the preliminary characterization of the isolates was done using the RQ strain. Routine tests for the presence of mycoplasmas were negative by agar culture and fluorescence tests for all the isolates except LN (the isolate described by Mitchell et al., 1979) . It should be noted that the latter isolate was the only one derived from the experiments described by Mitchell et al. (1978 Mitchell et al. ( , 1979 which was successfully passaged in the longer term. The remaining isolates were obtained later.
Neutralizing abilities of rabbit and human antisera against paramyxoviruses
Rabbit antisera prepared against purified SV5 (RQ strain) and PF-3 virus and rabbit antisera against other paramyxoviruses obtained from a variety of sources were analysed for their abilities to cross-neutralize a number of paramyxoviruses with results as shown in Table 2 . There were no demonstrable cross-reactions among the viruses tested except minor ones between the SV5 viruses (RQ and prototype) and PF-2 and between Sendai and PF-1 viruses. Similar neutralization tests on the sera from 62 patients show that about 22~ and 82~ of the sera were capable of neutralizing SV5 (RQ) and PF-2 respectively (Table 3 ). There were no significant differences in the neutralizing abilities of the sera from MS and non-MS patients. All of the MS sera with abilities to neutralize SV5 also neutralized PF-2 virus but there was no correlation between the titres of antibodies obtained, e.g. some sera had a higher titre against SV5 (RQ) passage, supernatants of infected cultures, 6 to 7 days in the case of MRC-5 and 3 to 4 days in the case of Vero cells, were harvested and aliquots were added to cell monolayers with maintenance medium. Virus stocks used in this study had the above passage history and were used after storage at -70 °C. Infectivity titres were about 10 v p.f.u./ml. 
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* Most of the serum samples positive for neutralizing antibody had titres ranging from 16 to 32. The highest neutralizing antibody titre was 64. The same sera were positive for both SV5 (prototype) and RQ neutralization. than against PF-2 virus and vice versa. Similarly, there were no significant differences in the mean titres of antibodies against SV5 (RQ) and PF-2 virus when MS and control sera were compared (data not shown).
Does the SV5-neutralizing activity in human sera result from a cross-reaction with PF-2?
Previous studies have shown that rabbit sera prepared against RQ and PF-2 do not immunoprecipitate the HN polypeptides of PF-2 and SV5 respectively (Goswami & Russell, 1982) , although other polypeptides (e.g. NP) were clearly very similar antigenically. To throw some light on the nature of the neutralizing antibodies against SV5 seen in some human sera, extracts of 3sS-labelled cells infected with RQ and PF-2 viruses were immunoprecipitated with human sera from both MS and non-MS patients. Fig. 1 shows that sera which neutralized SV5 clearly immunoprecipitated the SV5 HN polypeptide and sera which neutralized PF-2 precipitated the corresponding PF-2 HN polypeptide. Sera which were PF-2-positive and SV5-negative did not precipitate the SV5 HN polypeptide (data not shown). However, since monoclonal antibody studies (Goswami & Russell, 1983) had indicated that there is at least one cross-reacting epitope on the SV5 and PF-2 HN polypeptides (the SV5 HN-2 epitope detected using the C12 (Goswami & Russell, 1982) .
hybridoma), a further study tested the ability of the h u m a n sera to c o m p e t e with the specific SV5 HN-1 epitope as detected by the A12 hybridoma. Results of a r a d i o i m m u n e competition assay, as shown in Fig. 2 , indicate that a h u m a n serum which contains SV5-neutralizing antibodies did block the binding of the labelled monoclonal I g G to the specific SV5 HN-1 epitope whereas a h u m a n serum with a significant neutralization titre against PF-2 had no effect. The above results therefore imply that the observed SV5-neutralizing activity is specific for SV5 and not merely a cross-reaction from the i m m u n e response to PF-2 infection.
Immunoprecipitation of S V5 isolates
The five different SV5 isolates were further characterized by preparing extracts of 3sS-labelled infected Vero cells and i m m u n o p r e c i p i t a t i n g with R Q rabbit antiserum. Fig. 3 (a) shows that the electrophoretic mobilities of the polypeptides of four of the isolates were all similar refer to the molecular weights ( x 10 -3) of adenovirus marker polypeptides. HN, NP, F 1, P and M refer to mobilities of appropriate SV5 polypeptides (Goswami & Russell, 1982) .
although the H N and N P polypeptides of the LN isolate migrated more like the SV5 prototype strain than the RQ strain.. The other isolate NR was similar to RQ (data not shown). The HN polypeptides of RQ and SV5 (prototype) were precipitated by the A 12 hybridoma antibody (SV5 HN-1 epitope) whereas LN showed very little reaction in this test (Fig. 3b) . On the other hand, all were precipitated by the C12 (SV5 HN-2 epitope). Similar differences in terms of neutralization and HI by the A12 and C12 monoclonal antibodies and by the rabbit antisera were detected using the LN and RQ isolates (Table 4) . Thus, these experiments strongly suggest that the LN isolate, while having some antigenic similarity to the prototype SV5 strain, is significantly different from both the RQ and prototype strains. RQ and the remaining isolates also appear to have some antigenic differences from the prototype strain.
DISCUSSION
The experiments described in this study have indicated that about 20~ of the human sera examined have neutralizing antibodies against SV5. Moreover, complementary tests using a specific monoclonal antibody suggest that these antibodies are not derived from cross-reacting PF-2 antibodies but are specific for SV5 and therefore presumably reflect infection at some time by the virus. These studies have, as yet, given no indication of any disease associated with the infection or indeed of when and how it is acquired. Thus, although SV5 viruses with minor antigenic and electrophoretic differences were isolated after co-cultivation from MS bone marrow on separate occasions, serological analysis by neutralization of sera from MS patients and control sera did not demonstrate either a specific association with MS or elevated levels of antibody in the MS patients. Nevertheless, it is still not clear why only the bone marrows from MS patients should eventually yield infectious SV5 on co-cultivation and passage in vitro and the possibility that other factors such as virulence and immunological status may have a role cannot be dismissed.
Some earlier studies (Aulisio et al., 1964; Hsiung et al., 1963; Itoh et al., 1968) have shown that neutralizing and HI antibodies to SV5 are present in variable amounts in human sera. However, with the relatively crude techniques used in these initial investigations, it was not clear whether the antibodies reflected a cross-reaction with a related virus or a response to infection by SV5. The present experiments indicate that the latter is the most likely explanation and indeed highlight the lack of information currently available on cross-reactions between apparent paramyxoviruses and on strain variations within the genera. Moreover, it is notable that at least two different strains (exemplified by LN and RQ) were isolated in the course of the studies and suggests that the isolations were probably not related to a common source of contamination. However, it cannot be ruled out that differences arose as a result of selection during tissue culture passage.
We have also utilized the monoclonal antibodies to analyse directly bone marrow aspirates for the presence of SV5 antigens by fluorescent antibody methods. Preliminary experiments indicate that about 20 to 25~ of MS and non-MS bone marrow do elaborate specific SV5 antigens (our unpublished observations). The nature of the cells involved in this apparent infection by SV5 and the characteristics of the antigens detected are under study and may help to throw some further light on the significance of these observations.
It is pertinent to note that SV5-1ike viruses have apparently been isolated from a variety of tissues associated with human diseases (Hsiung et al., 1962; Robbins et al., 1981 ; Schultz & Habel, 1959) . There are also a number of reports of isolation from canines with respiratory disease (e.g. Cornwell et al., 1976 ) and it appears from serological data that the virus is widespread in dogs. In addition, SV5 has been isolated from a dog with neurological dysfunction (Baumgartner et al., 1981; Evermann et al., 1980) .
Taking the present studies into consideration, the overall results do suggest, therefore, that SV5 should be added to the list of paramyxoviruses which persistently infect man. Since the virus also appears to infect domestic animals as well as simians it does seem plausible to consider the human infection as being a zoonosis.
